John R. Garrett

Amministratore Delegato presso Glycosyn LLC

Health Technology

Profilo

John R.
Garrett is currently the Co-Chief Executive Officer at Glycosyn LLC and the Executive Director at Glycosyn Health Initiatives, Inc. He previously worked as a Director at Advanced Proteome Therapeutics Corp.

Posizioni attive di John R. Garrett

Società	Posizione	Inizio
Glycosyn LLC Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett.	Amministratore Delegato	-
Glycosyn Health Initiatives, Inc.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di John R. Garrett

Precedenti posizioni note di John R. Garrett

Società	Posizione	Fine
ADVANCED PROTEOME THERAPEUTICS CORPORATION	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di John R. Garrett

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John R. Garrett

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ADVANCED PROTEOME THERAPEUTICS CORPORATION	Health Technology

Aziende private	2
Glycosyn LLC Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett.	Health Technology
Glycosyn Health Initiatives, Inc.